Toggle light / dark theme

Scientists discover that 1 in 5 metal compounds display anti-fungal properties-they are non-toxic too.

Metal compounds could be the answer to the growing problem of drug-resistant fungal infections, according to new research published in the American Chemical Society on Sept .23.

The compounds could help develop much-needed antifungal drugs-particularly for immunocompromised patients susceptible to fungal infections.

This is both good and bad news.

A team of international researchers has revealed that viruses take cues from their surroundings to perform different actions. This implies that they have the ability to sense their and their host’s environment and decide whether or not it is suitable to spread infection, attack the host cells, multiply in number, or suspend activity at any given time.

The researchers believe that this discovery could further disclose various unknown aspects of the virus-host interaction and lead to the development of a new generation of antiviral drugs. During their study, they studied bacteriophages, also called “phages,” viruses that infect and harm bacteria, and discovered that the DNA of such viruses contains binding sites for a protein called CtrA.

Interestingly, a phage never produces CtrA, so why does its DNA have a binding site for the protein? While looking for an answer to this question, the researchers discovered an unheard power of the phages.

Ideally, the nanopore dimensions should be comparable to those of the analyte for the presence of the analyte to produce a measurable change in the ionic current amplitude above the noise level. Nanopores can be formed in several ways, with a wide range of pore diameters. Biological nanopores are formed by the self-assembly of either protein subunits, peptides or even DNA scaffolds in lipid bilayers or block copolymer membranes1,3,6,17,18. They possess atomically precise dimensions controlled by biopolymer sequences, providing the ability to recognize biomolecules with constriction diameters of ~1–10 nm. Solid-state nanopores are crafted in thin inorganic or plastic membranes (for example, SiNx), which allows the nanopores to have extended diameters of up to hundreds of nanometres, permitting the entry or analysis of large biomolecules and complexes. The tools for fabricating solid-state nanopores, which include electron/ion milling4,5, laser-based optical etching19,20 and the dielectric breakdown of ultrathin solid membranes21,22, can be used to manipulate nanopore size at the nanometre scale, but allow only limited control over the surface structure at the atomic level in contrast to biological nanopores. The chemical modification and genetic engineering of biological nanopores, or the introduction of biomolecules to functionalize solid-state nanopores23, can further enhance the interactions between a nanopore and analytes, improving the overall sensitivity and selectivity of the device2,17,24,25,26. This feature allows nanopores to controllably capture, identify and transport a wide variety of molecules and ions from bulk solution.

Nanopore technology was initially developed for the practicable stochastic sensing of ions and small molecules2,27,28. Subsequently, many developmental efforts were focused on DNA sequencing1,7,8,9. Now, however, nanopore applications extend well beyond sequencing, as the methodology has been adapted to analyse molecular heterogeneities and stochastic processes in many different biochemical systems (Fig. 1). First, a key advantage of nanopores lies in their ability to successively capture many single molecules one after the other at a relatively high rate, which allows nanopores to explore large populations of molecules at the single-molecule level in reasonable timeframes. Second, nanopores essentially convert the structural and chemical properties of the analytes into a measurable ionic current signal, even achieving enantiomer discrimination29. The technology can be used to report on multiple molecular features while circumventing the need for labelling chemistries, which may complicate the overall analysis process and affect the molecular structures. For example, nanopores can discriminate nearly 13 different amino acids in a label-free manner, including some with minute structural differences30. An important aspect is the ability of nanopores to identify species31 that lack suitable labels for signal amplification or whose information is hidden in the noise of analytical devices. Consequently, nanopores may serve well in molecular diagnostic applications required for precision medicine, which achieves the identification of nucleic acid, protein or metabolite analytes and other biomarkers11,32,33,34,35. Third, nanopores provide a well-defined scaffold for controllably designing and constructing biomimetic systems, which involve a complex network of biomolecular interactions. These nanopore systems track the binding dynamics of transported biomolecules as they interact with nanopore surfaces, hence serving as a platform for unravelling complex biological processes (for example, the transport properties of nuclear pore complexes)36,37,38,39. Fourth, chemical groups can be spatially aligned within a protein nanopore, providing a confined chemical environment for site-selective or regioselective covalent chemistry. This strategy has been used to engineer protein nanoreactors to monitor bond-breaking and bond-making events40,41.

Here we discuss the latest advances in nanopore technologies beyond DNA sequencing and the future trajectory of the field, as well as the opportunities and main challenges for the next decade. We specifically address the emerging nanopore methods for protein analysis and protein sequencing, single-molecule covalent chemistry, single-molecule analysis of clinical samples and insights into the use of biomimetic pores for analysing complex biological processes.

Summary: Study reveals altered brain dynamics in those with unresponsive arousal syndrome, previously known as “vegetative state”, and in those with minimally conscious state.

Source: University of Liege.

A study by the Human Brain Project (HBP), led by scientists from the University of Liège (Belgium), has explored new techniques that may help distinguish between two different neurological conditions in patients with severe brain damage and or in a coma. The results of this study have just been published in open access in the journal eLife.

The new material is far superior to today’s non-stick options.

Researchers at Tufts University have developed a method for developing silk-based materials that refuse to stick to water and exhibit non-stick properties that surpass those of current non-stick surfaces, according to a press release by the institution published on Friday.


“The success we had with modifying silk to repel water extends our successes with chemically modifying silk for other functionalities—such as the ability to change color, conduct electrical charge, or persist or degrade in a biological environment,” said David Kaplan, Stern Family Professor of Engineering at Tufts.

“As a protein, silk lends itself well to modular chemistry – the ability to ‘plug in’ different functional components on a natural scaffold.”

In addition to being implemented in medical devices, the new material could have uses as automotive windshields where rainwater just rolls off without using wipers, coatings on metals that help prevent rust, or on fabrics to make them easier to clean.

Tracking the severity and progression of Parkinson’s disease is a complicated but absolutely necessary task that leaves clinicians baffled. Now, according to an MIT report published on Wednesday, there may be a new device that can help physicians do just that.

Monitoring movement and gait speed

The invention is an in-home device that can monitor a patient’s movement and gait speed, “which can be used to evaluate Parkinson’s severity, the progression of the disease, and the patient’s response to medication.”

Summary: Researchers aim to map and track cellular changes in the human brain over a lifetime.

Source: UCSD

With a five-year, $126 million grant from the National Institutes of Health (NIH), a multi-institution team of researchers at University of California San Diego School of Medicine, Salk Institute for Biological Studies and elsewhere has launched a new Center for Multiomic Human Brain Cell Atlas.

U. Penn research finds protein associated with bone loss which may lead to treatment for osteoporosis, periodontitis, rheumatoid arthritis and fractures.


A study led by Shuying (Sheri) Yang of the School of Dental Medicine identified a new role for a protein that keeps osteoclasts—the cells that break down bone—in check, and may guide the development of new therapies to counter bone loss.